Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

1-methyl-3-isobutylxanthine has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Safa, M1
Kazemi, A1
Zaker, F1
Razmkhah, F1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro.
    Journal of receptor and signal transduction research, 2011, Volume: 31, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Apoptosis; Cell Line, Tumor; Colforsin; Cyclic AMP; Cyclic AMP-Dependen

2011